臨床試驗

[18F]FLT PET/CT in Rb+ Metastatic Breast Cancer

NCT：NCT02608216 · ACTIVE_NOT_RECRUITING

NCT IDNCT02608216

狀態ACTIVE_NOT_RECRUITING

SponsorUniversity of Pennsylvania (OTHER)

First posted2015-11-18

Last updated2026-10-07

簡要摘要

In this study positron emission tomography (PET/CT) imaging will be used to evaluate proliferative activity in sites of metastatic disease using the investigational radiotracer \[18F\]fluorothymidine (FLT).

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。